Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page. This reflects a version update to the site's content or template.
    Difference
    0.1%
    Check dated 2026-07-04T09:26:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's documentation/version.
    Difference
    0.1%
    Check dated 2026-06-27T05:29:39.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated from the previous 'Intervention / Treatment' formatting, with a site revision noted as v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-13T00:32:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing v3.5.4, indicating a minor site update to the page rendering or metadata. It does not change the study details or results displayed.
    Difference
    0.1%
    Check dated 2026-06-05T21:35:34.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, signaling a new release of the study record interface. This update reflects a minor backend/format change and does not modify the study data.
    Difference
    0.1%
    Check dated 2026-05-15T14:25:21.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s displayed software/content revision updated from v3.5.2 to v3.5.3, reflecting a site-level release with no apparent change to the underlying study details shown.
    Difference
    0.1%
    Check dated 2026-04-24T06:02:07.000Z thumbnail image

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.